Editorial Board
Pamela Pinzani
Associate Professor, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Italy · Italy
Editorial leadership for Journal of Thyroid Cancer ISSN 2574-4496
Research interests
- Clinical Biochemistry
- Clinical Molecular Biology
Biography
Pamela Pinzani graduated in 1985 from Florence University in Italy discussing a thesis at the Faculty of Biology.
After post-degree periods as vis.
Publications:
- Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma.
- Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma.
- Powerful qPCR assays for the early detection of latent invaders: interdisciplinary approaches in clinical cancer research and plant pathology.
- High-Resolution Melting Analysis: A new molecular approach for the early detection of Diplodia pinea in Austrian pine.
- Detection of Diplodia pinea in asymptomatic pine shoots and its relation to the Normalized Insolation index.
- Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions.
- The potential of proteogenomics in oncology.
- Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.
- Single circulating tumor cell sequencing as an advanced tool in cancer management.
- BRAF and KIT somatic mutations are present in amelanotic melanoma.
Selected publications
- Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method 2014 cited 51×
- Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification 2017 cited 49×
- Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 2021 cited 41×
- Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers 2016 cited 18×
- The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients 2017 cited 12×
- Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 2023 cited 8×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JTC for your work?
This journal is guided by Pamela Pinzani (Associate Professor, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Italy) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.